Label-Free Electrochemical Immunosensor for Ultrasensitive Detection of Carbohydrate Antigen 125 Based on Antibody-Immobilized Biocompatible MOF-808/CNT

Sudip Biswas,Qingchun Lan,Yao Xie,Xin Sun,Yang Wang

DOI: https://doi.org/10.1021/acsami.0c14946

2021-01-05

Abstract:In this work, a nanocomposite of Zr-trimesic acid MOF (MOF-808) with carbon nanotube (CNT) was synthesized through an in situ formation of MOF-808 on the activated CNT. The synthesized materials were characterized by powder X-ray diffraction, transmission electron microscopy, X-ray photoluminescence spectroscopy, Brunauer-Emmett-Teller, Fourier transform infrared spectroscopy, and Raman spectroscopy. The protein compatible nature with high surface area and electrocatalytic ability of MOF-808 was utilized to construct an immunosensor for ultra low-level detection of the ovarian cancer biomarker, carbohydrate antigen 125 (CA 125). The mutual benefit of each constituent of the MOF-808/CNT composite was capable of producing highly enhanced electrochemical properties. A glassy carbon electrode modified with MOF-808/CNT was used as a platform to fabricate a label-free electrochemical immunosensor. The antibody binding sites of MOF-808/CNT were enriched by functionalization with streptavidin. The immunosensor exhibited two linear determination ranges of 0.001-0.1 and 0.1-30 ng·mL^-1, and the calculated limit of detection was 0.5 pg·mL^-1 (S/N 3). The immunosensor showed excellent reproducibility and selectivity. The patient serum sample analysis was cross-verified with the electrochemiluminescence method with a relative error of 105-110%.

materials science, multidisciplinary,nanoscience & nanotechnology

What problem does this paper attempt to address?

This paper aims to solve the problem of ultra - low - level detection of Carbohydrate Antigen 125 (CA 125), a biomarker for ovarian cancer. Specifically, the researchers developed a label - free electrochemical immunosensor based on antibody - immobilized biocompatible MOF - 808/CNT nanocomposites to achieve ultrasensitive detection of CA 125. Through this sensor, simple, low - cost and highly sensitive detection of CA 125 in clinical samples can be achieved, which is of great significance for the early diagnosis and prognostic evaluation of ovarian cancer.

The key point of the paper is to utilize the unique properties of the metal - organic framework (MOF - 808) and carbon nanotube (CNT) composites, such as high specific surface area, good biocompatibility and enhanced electrocatalytic activity, to construct a high - performance immunosensor. In addition, the number of antibody binding sites was further increased by introducing streptavidin through functional modification, thereby enhancing the detection performance of the sensor. The experimental results show that the immunosensor exhibits two linear response ranges in the concentration range of 0.001 to 30 ng·mL\(^{-1}\), and the detection limit is as low as 0.5 pg·mL\(^{-1}\), showing excellent reproducibility and selectivity. These characteristics make the sensor perform well in the analysis of actual patient serum samples. Compared with the electrochemiluminescence method, the relative error is only 105% to 110%, proving its potential in clinical applications.